Karyotypic identification of abnormal clones preceding morphological changes or occurring with no definite morphological features of myelodysplastic syndrome: A preliminary study

Laboratory Hematology

Volumn 13, Issue 1, 2007, Pages 17-21

  Han, Jin Yeong ^a,b   Theil, Karl S ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Dong A University College of Medicine   (South Korea)

Author keywords

Bone marrow morphology; Clonal abnormalities; Cytogenetic analysis; Dysplastic feature; Myelodysplastic syndrome

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW CANCER; CHROMOSOME 11Q; CHROMOSOME 4; CHROMOSOME LOSS; CYTOGENETICS; CYTOPENIA; FEMALE; FOLLOW UP; GENE DELETION; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; MORPHOLOGY; MYELODYSPLASTIC SYNDROME; TRISOMY 8; Y CHROMOSOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BONE MARROW EXAMINATION; CHROMOSOME ABERRATIONS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PANCYTOPENIA;

EID: 34147218782     PISSN: 10802924     EISSN: None     Source Type: Journal    
DOI: 10.1532/LH96.06047     Document Type: Article

References (25)

1. Bain BJ. Overview. Cytogenetics in haematology. Best Prac Res Clin Haematol. 2001;14:463-477.
2. Olney JH, Le Beau MM. The cytogenetics of myelodysplastic syndromes. Best Prac Res Clin Haematol. 2001;14:479-495.
3. Brunning RD, Bennett JM, Flandrin G, et al. Myelodysplastic syndromes. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2001:61-73.
4. Traweek ST, Slovak MS, Nademanee AP, Brynes RK, Niland JC, Forman SJ. Clonal karyotypic hematopoietic cell abnormalities occurring after autologous bone marrow transplantation for Hodgkin's disease and non-Hodgkin's lymphoma. Blood. 1994;84:957-963.
5. Laurenti L, Chiusolo P, Garzia M, et al. Periodic morphologic, cytogenetic and clonality evaluation after autologous peripheral blood progenitor cell transplantation in patients with lymphoproliferative malignancies. Haematologica. 2002;87:59-66.
6. Lillington DM, Jaju RJ, Shankar AG, et al. Cytogenetic and molecular evidence of marrow involvement in extramedullary acute myeloid leukaemia. Br J Haematol. 2000;110:547-551.
7. Johansson B, Fioretos T, Kullendorf CM, et al. Granulocytic sarcomas in body cavities in childhood acute myeloid leukemias with 11q23/MLL rearrangements. Genes Chromosomes Cancer. 2000;27:136-142.
8. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 1982;51:189-199.
9. Shaffer LG, Tommerup N. ISCN. An International System for Human Cytogenetic Nomenclature. Basel: Karger; 2005.
10. Cherian S, Bagg A. The genetics of the myelodysplastic syndromes: classical cytogenetics and recent molecular insights. Hematology. 2006;11:1-13.
11. Steensma DE Dewald GW Hodnefield JM, et al. Clonal cytogenetic abnormalities in bone marrow specimens without dear morphological evidence of dysplasia: a form fruste of myelodysplasia? Leuk Res. 2003;27:235-242.
12. Gimwade D. The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia. Best Prac Res Clin Haematol. 2001;14:497-529.
13. Sole F, Espinet B, Sanz, GF, et al. Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes. Br J Haematol. 2000;108:346-356.
14. Huret JL. t(3;5) (q25;q34). Atlas Genet Cytogenet Oncol Haematol. August 1997. URL: http://www.infobiogen.fr/services/chrom-cancer/ Anomalies/t0305.html.
15. Dror Y, Squire J, Durie P, Freedman MH. Malignant myeloid transformation with isochromosome 7q in Shwachman-Diamond syndrome. Leukemia. 1998;12:1591-1595.
16. Wiktor A, Rybicki BA, Piao ZS, et al. Clinical significance of Y chromosome loss in hematologic disease. Genes Chromosomes Cancer. 2000;27:11-16.
17. Shah N, Oseth L, Tran H, Hirsdi B, LeBien TW. Clonal variation in the B-lineage acute lymphoblastic leukemia response to multiple cytokines and bone marrow stromal cells. Cancer Res. 2001;61:5268-5274.
18. Bernasconi P, Astori C, Cavigliano PM, et al. Cytogenetic and FISH analyses in five patients with hypoplastic bone marrow. Leukemia. 2000;14:1322-1323.
19. Araten DJ, Swirsky D, Karadimitris A, et al. Cytogenetic and morphological abnormalities in paroxysmal nocturnal haemoglobinuria. Br J Haematol. 2001;115:360-368.
20. Moormeier JA, Rubin CM, Le Beau MM, Vardiman JW, Larson RA, Winter JN. Trisomy 6: a recurring cytogenetic abnormality associated with marrow hypoplasia. Blood. 1991;77:1397-1401.
21. Mantadakis E, Shannon KM, Singer DA, et al. Transient monosomy 7. A case series in children and review of the literature. Cancer. 1999;85:2655-2661.
22. Hall GW. Childhood myeloid leukaemias. Best Prac Res Clin Haematol. 2001;14:573-591.
23. Matsuda A, Yagasaki F, jinnai I, et al. Trisomy 8 may not be related to the pathogenesis of myelodysplastic syndromes: disappearance of trisomy 8 in a patient with refractory anaemia without haematological improvement. Eur J Haematol. 1998;60:260-261.
24. Maserati E, Aprili F, Vinante F, et al. Trisomy 8 in myelodysplasia and acute leukemia is constitutional in 15-20% of cases. Genes Chromosomes Cancer. 2002;33:93-97.
25. Wlodarska I, Martin-Garcia N, Achten R, et al. Fluorescence in situ hybridization study of chromosome 7 aberrations in hepatosplenic T-cell lymphoma: isochromosome 7q as a common abnormality accumulating in forms with features of cytologic progression. Genes Chromosomes Cancer 2002;33:243-251.